img

Global General Anesthesia Medicine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global General Anesthesia Medicine Market Research Report 2024

General anesthetics are medicines that render a patient reversibly unconscious and unresponsive in order to allow surgeons to operate on that patient.
According to Mr Accuracy reports’s new survey, global General Anesthesia Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole General Anesthesia Medicine market research.
Key companies engaged in the General Anesthesia Medicine industry include Astrazeneca, B.Braun, Fresenius-Kabi, Hikma Pharmaceuticals, Maruishi, Nhwa, Piramal, AbbVie and Baxter Healthcare, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of General Anesthesia Medicine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole General Anesthesia Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global General Anesthesia Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Astrazeneca
B.Braun
Fresenius-Kabi
Hikma Pharmaceuticals
Maruishi
Nhwa
Piramal
AbbVie
Baxter Healthcare
Hengrui
Lunan
Mylan
Segment by Type
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others

Segment by Application


Intravenous Anesthetics
Inhalational Anesthetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The General Anesthesia Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Anesthesia Medicine Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Sevoflurane
1.2.6 Isoflurane
1.2.7 Others
1.3 Market by Application
1.3.1 Global General Anesthesia Medicine Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anesthesia Medicine Market Perspective (2018-2034)
2.2 General Anesthesia Medicine Growth Trends by Region
2.2.1 Global General Anesthesia Medicine Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 General Anesthesia Medicine Historic Market Size by Region (2018-2023)
2.2.3 General Anesthesia Medicine Forecasted Market Size by Region (2024-2034)
2.3 General Anesthesia Medicine Market Dynamics
2.3.1 General Anesthesia Medicine Industry Trends
2.3.2 General Anesthesia Medicine Market Drivers
2.3.3 General Anesthesia Medicine Market Challenges
2.3.4 General Anesthesia Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anesthesia Medicine Players by Revenue
3.1.1 Global Top General Anesthesia Medicine Players by Revenue (2018-2023)
3.1.2 Global General Anesthesia Medicine Revenue Market Share by Players (2018-2023)
3.2 Global General Anesthesia Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anesthesia Medicine Revenue
3.4 Global General Anesthesia Medicine Market Concentration Ratio
3.4.1 Global General Anesthesia Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anesthesia Medicine Revenue in 2024
3.5 General Anesthesia Medicine Key Players Head office and Area Served
3.6 Key Players General Anesthesia Medicine Product Solution and Service
3.7 Date of Enter into General Anesthesia Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anesthesia Medicine Breakdown Data by Type
4.1 Global General Anesthesia Medicine Historic Market Size by Type (2018-2023)
4.2 Global General Anesthesia Medicine Forecasted Market Size by Type (2024-2034)
5 General Anesthesia Medicine Breakdown Data by Application
5.1 Global General Anesthesia Medicine Historic Market Size by Application (2018-2023)
5.2 Global General Anesthesia Medicine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America General Anesthesia Medicine Market Size (2018-2034)
6.2 North America General Anesthesia Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America General Anesthesia Medicine Market Size by Country (2018-2023)
6.4 North America General Anesthesia Medicine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anesthesia Medicine Market Size (2018-2034)
7.2 Europe General Anesthesia Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe General Anesthesia Medicine Market Size by Country (2018-2023)
7.4 Europe General Anesthesia Medicine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anesthesia Medicine Market Size (2018-2034)
8.2 Asia-Pacific General Anesthesia Medicine Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific General Anesthesia Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific General Anesthesia Medicine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anesthesia Medicine Market Size (2018-2034)
9.2 Latin America General Anesthesia Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America General Anesthesia Medicine Market Size by Country (2018-2023)
9.4 Latin America General Anesthesia Medicine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anesthesia Medicine Market Size (2018-2034)
10.2 Middle East & Africa General Anesthesia Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa General Anesthesia Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa General Anesthesia Medicine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Detail
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca General Anesthesia Medicine Introduction
11.1.4 Astrazeneca Revenue in General Anesthesia Medicine Business (2018-2023)
11.1.5 Astrazeneca Recent Development
11.2 B.Braun
11.2.1 B.Braun Company Detail
11.2.2 B.Braun Business Overview
11.2.3 B.Braun General Anesthesia Medicine Introduction
11.2.4 B.Braun Revenue in General Anesthesia Medicine Business (2018-2023)
11.2.5 B.Braun Recent Development
11.3 Fresenius-Kabi
11.3.1 Fresenius-Kabi Company Detail
11.3.2 Fresenius-Kabi Business Overview
11.3.3 Fresenius-Kabi General Anesthesia Medicine Introduction
11.3.4 Fresenius-Kabi Revenue in General Anesthesia Medicine Business (2018-2023)
11.3.5 Fresenius-Kabi Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Detail
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals General Anesthesia Medicine Introduction
11.4.4 Hikma Pharmaceuticals Revenue in General Anesthesia Medicine Business (2018-2023)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Maruishi
11.5.1 Maruishi Company Detail
11.5.2 Maruishi Business Overview
11.5.3 Maruishi General Anesthesia Medicine Introduction
11.5.4 Maruishi Revenue in General Anesthesia Medicine Business (2018-2023)
11.5.5 Maruishi Recent Development
11.6 Nhwa
11.6.1 Nhwa Company Detail
11.6.2 Nhwa Business Overview
11.6.3 Nhwa General Anesthesia Medicine Introduction
11.6.4 Nhwa Revenue in General Anesthesia Medicine Business (2018-2023)
11.6.5 Nhwa Recent Development
11.7 Piramal
11.7.1 Piramal Company Detail
11.7.2 Piramal Business Overview
11.7.3 Piramal General Anesthesia Medicine Introduction
11.7.4 Piramal Revenue in General Anesthesia Medicine Business (2018-2023)
11.7.5 Piramal Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie General Anesthesia Medicine Introduction
11.8.4 AbbVie Revenue in General Anesthesia Medicine Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Detail
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare General Anesthesia Medicine Introduction
11.9.4 Baxter Healthcare Revenue in General Anesthesia Medicine Business (2018-2023)
11.9.5 Baxter Healthcare Recent Development
11.10 Hengrui
11.10.1 Hengrui Company Detail
11.10.2 Hengrui Business Overview
11.10.3 Hengrui General Anesthesia Medicine Introduction
11.10.4 Hengrui Revenue in General Anesthesia Medicine Business (2018-2023)
11.10.5 Hengrui Recent Development
11.11 Lunan
11.11.1 Lunan Company Detail
11.11.2 Lunan Business Overview
11.11.3 Lunan General Anesthesia Medicine Introduction
11.11.4 Lunan Revenue in General Anesthesia Medicine Business (2018-2023)
11.11.5 Lunan Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan General Anesthesia Medicine Introduction
11.12.4 Mylan Revenue in General Anesthesia Medicine Business (2018-2023)
11.12.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global General Anesthesia Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Propofol
Table 3. Key Players of Etomidate
Table 4. Key Players of Midazolam
Table 5. Key Players of Sevoflurane
Table 6. Key Players of Isoflurane
Table 7. Key Players of Others
Table 8. Global General Anesthesia Medicine Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 9. Global General Anesthesia Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 10. Global General Anesthesia Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global General Anesthesia Medicine Market Share by Region (2018-2023)
Table 12. Global General Anesthesia Medicine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 13. Global General Anesthesia Medicine Market Share by Region (2024-2034)
Table 14. General Anesthesia Medicine Market Trends
Table 15. General Anesthesia Medicine Market Drivers
Table 16. General Anesthesia Medicine Market Challenges
Table 17. General Anesthesia Medicine Market Restraints
Table 18. Global General Anesthesia Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global General Anesthesia Medicine Market Share by Players (2018-2023)
Table 20. Global Top General Anesthesia Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthesia Medicine as of 2024)
Table 21. Ranking of Global Top General Anesthesia Medicine Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by General Anesthesia Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players General Anesthesia Medicine Product Solution and Service
Table 25. Date of Enter into General Anesthesia Medicine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global General Anesthesia Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global General Anesthesia Medicine Revenue Market Share by Type (2018-2023)
Table 29. Global General Anesthesia Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 30. Global General Anesthesia Medicine Revenue Market Share by Type (2024-2034)
Table 31. Global General Anesthesia Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global General Anesthesia Medicine Revenue Market Share by Application (2018-2023)
Table 33. Global General Anesthesia Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 34. Global General Anesthesia Medicine Revenue Market Share by Application (2024-2034)
Table 35. North America General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America General Anesthesia Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America General Anesthesia Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 39. Europe General Anesthesia Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe General Anesthesia Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 41. Asia-Pacific General Anesthesia Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 42. Asia-Pacific General Anesthesia Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific General Anesthesia Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 44. Latin America General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Latin America General Anesthesia Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America General Anesthesia Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 47. Middle East & Africa General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 48. Middle East & Africa General Anesthesia Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa General Anesthesia Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 50. Astrazeneca Company Detail
Table 51. Astrazeneca Business Overview
Table 52. Astrazeneca General Anesthesia Medicine Product
Table 53. Astrazeneca Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 54. Astrazeneca Recent Development
Table 55. B.Braun Company Detail
Table 56. B.Braun Business Overview
Table 57. B.Braun General Anesthesia Medicine Product
Table 58. B.Braun Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 59. B.Braun Recent Development
Table 60. Fresenius-Kabi Company Detail
Table 61. Fresenius-Kabi Business Overview
Table 62. Fresenius-Kabi General Anesthesia Medicine Product
Table 63. Fresenius-Kabi Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 64. Fresenius-Kabi Recent Development
Table 65. Hikma Pharmaceuticals Company Detail
Table 66. Hikma Pharmaceuticals Business Overview
Table 67. Hikma Pharmaceuticals General Anesthesia Medicine Product
Table 68. Hikma Pharmaceuticals Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 69. Hikma Pharmaceuticals Recent Development
Table 70. Maruishi Company Detail
Table 71. Maruishi Business Overview
Table 72. Maruishi General Anesthesia Medicine Product
Table 73. Maruishi Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 74. Maruishi Recent Development
Table 75. Nhwa Company Detail
Table 76. Nhwa Business Overview
Table 77. Nhwa General Anesthesia Medicine Product
Table 78. Nhwa Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 79. Nhwa Recent Development
Table 80. Piramal Company Detail
Table 81. Piramal Business Overview
Table 82. Piramal General Anesthesia Medicine Product
Table 83. Piramal Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 84. Piramal Recent Development
Table 85. AbbVie Company Detail
Table 86. AbbVie Business Overview
Table 87. AbbVie General Anesthesia Medicine Product
Table 88. AbbVie Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 89. AbbVie Recent Development
Table 90. Baxter Healthcare Company Detail
Table 91. Baxter Healthcare Business Overview
Table 92. Baxter Healthcare General Anesthesia Medicine Product
Table 93. Baxter Healthcare Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 94. Baxter Healthcare Recent Development
Table 95. Hengrui Company Detail
Table 96. Hengrui Business Overview
Table 97. Hengrui General Anesthesia Medicine Product
Table 98. Hengrui Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 99. Hengrui Recent Development
Table 100. Lunan Company Detail
Table 101. Lunan Business Overview
Table 102. Lunan General Anesthesia Medicine Product
Table 103. Lunan Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 104. Lunan Recent Development
Table 105. Mylan Company Detail
Table 106. Mylan Business Overview
Table 107. Mylan General Anesthesia Medicine Product
Table 108. Mylan Revenue in General Anesthesia Medicine Business (2018-2023) & (US$ Million)
Table 109. Mylan Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global General Anesthesia Medicine Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global General Anesthesia Medicine Market Share by Type: 2024 VS 2034
Figure 3. Propofol Features
Figure 4. Etomidate Features
Figure 5. Midazolam Features
Figure 6. Sevoflurane Features
Figure 7. Isoflurane Features
Figure 8. Others Features
Figure 9. Global General Anesthesia Medicine Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 10. Global General Anesthesia Medicine Market Share by Application: 2024 VS 2034
Figure 11. Intravenous Anesthetics Case Studies
Figure 12. Inhalational Anesthetics Case Studies
Figure 13. General Anesthesia Medicine Report Years Considered
Figure 14. Global General Anesthesia Medicine Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global General Anesthesia Medicine Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global General Anesthesia Medicine Market Share by Region: 2024 VS 2034
Figure 17. Global General Anesthesia Medicine Market Share by Players in 2024
Figure 18. Global Top General Anesthesia Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthesia Medicine as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by General Anesthesia Medicine Revenue in 2024
Figure 20. North America General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America General Anesthesia Medicine Market Share by Country (2018-2034)
Figure 22. United States General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe General Anesthesia Medicine Market Share by Country (2018-2034)
Figure 26. Germany General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific General Anesthesia Medicine Market Share by Region (2018-2034)
Figure 34. China General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America General Anesthesia Medicine Market Share by Country (2018-2034)
Figure 42. Mexico General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa General Anesthesia Medicine Market Share by Country (2018-2034)
Figure 46. Turkey General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia General Anesthesia Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Astrazeneca Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 49. B.Braun Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 50. Fresenius-Kabi Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 51. Hikma Pharmaceuticals Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 52. Maruishi Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 53. Nhwa Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 54. Piramal Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 56. Baxter Healthcare Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 57. Hengrui Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 58. Lunan Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 59. Mylan Revenue Growth Rate in General Anesthesia Medicine Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed